By Sneha S K and Amina Niasse Feb 23 (Reuters) - Online telehealth company Hims & Hers Health, which sells weight-loss drugs, ...
Feb 23 (Reuters) - Online telehealth company Hims & Hers Health forecast 2026 revenue above estimates on Monday, betting on ...
Hims & Hers Health (NYSE:HIMS) executives used the company’s fourth-quarter and full-year 2025 earnings call to emphasize ...
Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.
By Christy Santhosh Feb 19 (Reuters) - Hims & Hers Health said on Thursday it will acquire Australian digital health company ...
2hon MSN
Hims & Hers’ expansion plans — as well as its Super Bowl ad — have investors worried about profits
The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary declarations. The dynamics we have seen over the last eighteen months, including U.S. prices for injectable ...
Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...
The telehealth platform said it expects growth to continue this year, though its first quarter guidance [came in short]( ...
A whopping 85% of men experience significantly thinning hair by age 50, and two-thirds experience noticeable hair loss by age 35. So, while Hims provides access to a number of different prescription ...
Hims & Hers Health, Inc. ( HIMS) Q4 2025 Earnings Call February 23, 2026 5:00 PM EST ...
Q4 2025 earnings call recap: revenue, EBITDA, subscriber growth, new specialties, and international expansion outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results